Hepatocellular Cancer
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-computed tomography has shown mixed use in detecting hepatocellular carcinoma (HCC) but is the most sensitive modality for detecting extra-hepatic metastases. This chapter will answer the common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in HCC.